Amanote Research

Amanote Research

    RegisterSign In

Polycystic Liver Disease: The Benefits of Targeting cAMP

Clinical Gastroenterology and Hepatology - United Kingdom
doi 10.1016/j.cgh.2016.03.008
Full Text
Open PDF
Abstract

Available in full text

Categories
HepatologyGastroenterology
Date

July 1, 2016

Authors
Nicholas F. LarussoTatyana V. MasyukMarie C. Hogan
Publisher

Elsevier BV


Related search

Diagnosis and Percutaneous Puncture Treatment of Polycystic Liver and Hepatorenal Polycystic Disease

Vestnik of Saint Petersburg University. Medicine
2017English

Autosomal Dominant Polycystic Liver Disease: A Second Family

Clinical Genetics
Genetics
2008English

Liver Involvement in Early Autosomal-Dominant Polycystic Kidney Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

Isolated Polycystic Liver Disease and Aneurism: A Case Report

Annals of Translational Medicine
Medicine
2016English

Mutations in SEC63 Cause Autosomal Dominant Polycystic Liver Disease

Nature Genetics
Genetics
2004English

Activation of P-TEFb by cAMP-PKA Signaling in Autosomal Dominant Polycystic Kidney Disease

Science advances
Multidisciplinary
2019English

Polycystic Liver Disease and Sarcoidosis: Unusual Coexisting Etiologies of Portal Hypertension

Cureus
2017English

A Case Report of Frequent Familial Aggregation of Polycystic Liver Disease.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1991English

Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease

Mayo Clinic Proceedings: Innovations, Quality & Outcomes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy